The effect of insulin-loaded trimethylchitosan nanoparticles on rats with diabetes type I

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Endocrinology

Background:

• Diabetes mellitus type one is a chronic condition requiring lifelong insulin therapy.
• Conventional insulin delivery methods face challenges with bioavailability and stability.
• Nanoparticle-based drug delivery systems offer potential for improved therapeutic outcomes.

Purpose of the Study:

• To evaluate the efficacy of insulin-loaded trimethylchitosan nanoparticles.
• To assess the impact of these nanoparticles on diabetes-related complications.
• To compare nanoparticle insulin with conventional insulin treatment.

Main Methods:

• Twenty-five male Wistar rats were used, divided into control and treatment groups.
• Treatment involved either insulin-loaded trimethylchitosan nanoparticles or trade insulin over two weeks.
• Key parameters including blood glucose, biomarkers, and gene expression were analyzed.

Main Results:

• Both insulin treatments reduced liver steatosis and fatty degeneration.
• Amelioration of blood glucose, serum biomarkers, and oxidant/antioxidant parameters was observed.
• Insulin nanoparticles showed potency in attenuating hyperglycemia, oxidative stress, and inflammation, indicating bioavailability.

Conclusions:

• Insulin-loaded trimethylchitosan nanoparticles are effective in mitigating destructive effects of type one diabetes.
• The nanoparticle formulation demonstrates significant bioavailability and therapeutic potential.
• This approach offers a promising alternative for insulin delivery in diabetes management.